Delivery Order SPE2DX22D0029-SPE2D826F05QA
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $35,100.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $27,634.84 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, for completion by November 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,796.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with completion expected by November 4, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order was placed to the...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20,927.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $8,457.68 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,358.70 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 27, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $11,176.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 27, 2025, with completion targeted for October 28, 2025. This non-set-aside competitive award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor vehicle running through December 2026. AmerisourceBergen,...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F05QADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a firm fixed price delivery order valued at $2,078.36 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 12, 2025, with an ultimate completion date of November 13, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office location and will supply pharmaceutical products and medical supplies to support federal military and veteran healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, delivering an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's contract history with DLA demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders. This delivery order is part of AmerisourceBergen's comprehensive role as a prime vendor supporting global pharmaceutical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/12/25 |